Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today’s treat-to-target era

Overview of attention for article published in Experimental Hematology & Oncology, July 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter: 2 X users

patent: 1 patent

Citations

dimensions_citation: 29 Dimensions

Readers on

mendeley: 44 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 4 X posts from 2 X users, with an upper bound of 2,447 followers.

Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today’s treat-to-target era | Experimental Hematology & Oncology | Full Text https://t.co/UBAFdQg6tJ

17 Apr 2024

Reply Repost Favourite

Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today’s treat-to-target era - PMC https://t.co/mpS6nDqkMJ

21 Aug 2023

Reply Repost Favourite

Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today’s treat-to-target era - PMC https://t.co/mpS6nDqSCh

16 May 2023

Reply Repost Favourite

Research on the NHL: Interferon therapies https://t.co/aK1prZUPxa https://t.co/wx9zy090XB

25 Jun 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.